TNFR-associated factor 6 and TGF-β-activated kinase 1 control signals for a senescence response by an endosomal NK cell receptor

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 714-721

  Rajagopalan, Sumati ^a   Lee, Elizabeth C ^a   DuPrie, Matthew L ^a   Long, Eric O ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL4; NATURAL KILLER CELL RECEPTOR; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ANGIOGENESIS; ARTICLE; CONTROLLED STUDY; ENDOSOME; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE FUNCTION; MUTATIONAL ANALYSIS; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN SECRETION; SENESCENCE; SIGNAL TRANSDUCTION;

AMINO ACID MOTIFS; CELL AGING; CELL LINE; CYTOPLASM; ENDOSOMES; HEK293 CELLS; HUMANS; INTERLEUKIN-8; KILLER CELLS, NATURAL; MAP KINASE KINASE KINASES; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, KIR2DL4; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTORS;

EID: 84892777046     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302384     Document Type: Article

References (28)

1. Parham, P., and A. Moffett. 2013. Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution. Nat. Rev. Immunol. 13: 133-144.
2. Long, E. O., H. S. Kim, D. Liu, M. E. Peterson, and S. Rajagopalan. 2013. Controlling natural killer cell responses: integration of signals for activation and inhibition. Annu. Rev. Immunol. 31: 227-258.
3. Rajagopalan, S., and E. O. Long. 2012. KIR2DL4 (CD158d): An activation receptor for HLA-G. Front Immunol 3: 258.
4. Rajagopalan, S., Y. T. Bryceson, S. P. Kuppusamy, D. E. Geraghty, A. van der Meer, I. Joosten, and E. O. Long. 2006. Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4: e9.
5. Rajagopalan, S., M. W. Moyle, I. Joosten, and E. O. Long. 2010. DNA-PKcs controls an endosomal signaling pathway for a proinflammatory response by natural killer cells. Sci. Signal. 3: ra14.
6. Rajagopalan, S., and E. O. Long. 2012. Cellular senescence induced by CD158d reprograms natural killer cells to promote vascular remodeling. Proc. Natl. Acad. Sci. USA 109: 20596-20601.
7. Carosella, E. D., B. Favier, N. Rouas-Freiss, P. Moreau, and J. Lemaoult. 2008. Beyond the increasing complexity of the immunomodulatory HLA-G molecule. Blood 111: 4862-4870.
8. Moffett-King, A. 2002. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2: 656-663. (Pubitemid 37328723)
9. Koopman, L. A., H. D. Kopcow, B. Rybalov, J. E. Boyson, J. S. Orange, F. Schatz, R. Masch, C. J. Lockwood, A. D. Schachter, P. J. Park, and J. L. Strominger. 2003. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J. Exp. Med. 198: 1201-1212. (Pubitemid 37323385)
10. Rajagopalan, S., J. Fu, and E. O. Long. 2001. Cutting edge: induction of IFNgamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167: 1877-1881. (Pubitemid 32747490)
11. Ye, H., J. R. Arron, B. Lamothe, M. Cirilli, T. Kobayashi, N. K. Shevde, D. Segal, O. K. Dzivenu, M. Vologodskaia, M. Yim, et al. 2002. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 418: 443-447. (Pubitemid 34826847)
12. Li, Q., M. M. Harraz, W. Zhou, L. N. Zhang, W. Ding, Y. Zhang, T. Eggleston, C. Yeaman, B. Banfi, and J. F. Engelhardt. 2006. Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol. 26: 140-154.
13. Oakley, F. D., R. L. Smith, and J. F. Engelhardt. 2009. Lipid rafts and caveolin-1 coordinate interleukin-1beta (IL-1beta)-dependent activation of NFkappaB by controlling endocytosis of Nox2 and IL-1beta receptor 1 from the plasma membrane. J. Biol. Chem. 284: 33255-33264.
14. Chen, Y., J. Chen, Y. Xiong, Q. Da, Y. Xu, X. Jiang, and H. Tang. 2006. Internalization of CD40 regulates its signal transduction in vascular endothelial cells. Biochem. Biophys. Res. Commun. 345: 106-117.
15. Miah, S. M., A. K. Purdy, N. B. Rodin, A. W. MacFarlane, IV, J. Oshinsky, D. A. Alvarez-Arias, and K. S. Campbell. 2011. Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-kB signaling. J. Immunol. 186: 2959-2969.
16. Häcker, H., P. H. Tseng, and M. Karin. 2011. Expanding TRAF function: TRAF3 as a tri-faced immune regulator. Nat. Rev. Immunol. 11: 457-468.
17. Wang, C., L. Deng, M. Hong, G. R. Akkaraju, J. Inoue, and Z. J. Chen. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412: 346-351. (Pubitemid 32694385)
18. Ninomiya-Tsuji, J., K. Kishimoto, A. Hiyama, J. Inoue, Z. Cao, and K. Matsumoto. 1999. The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398: 252-256.
19. Oeckinghaus, A., M. S. Hayden, and S. Ghosh. 2011. Crosstalk in NF-kB signaling pathways. Nat. Immunol. 12: 695-708.
20. Sato, S., H. Sanjo, K. Takeda, J. Ninomiya-Tsuji, M. Yamamoto, T. Kawai, K. Matsumoto, O. Takeuchi, and S. Akira. 2005. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 6: 1087-1095. (Pubitemid 41541786)
21. Ninomiya-Tsuji, J., T. Kajino, K. Ono, T. Ohtomo, M. Matsumoto, M. Shiina, M. Mihara, M. Tsuchiya, and K. Matsumoto. 2003. A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J. Biol. Chem. 278: 18485-18490. (Pubitemid 36799472)
22. Kuilman, T., and D. S. Peeper. 2009. Senescence-messaging secretome: SMSing cellular stress. Nat. Rev. Cancer 9: 81-94.
23. Coppé, J. P., P. Y. Desprez, A. Krtolica, and J. Campisi. 2010. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5: 99-118.
24. Rajagopalan, S. 2010. Endosomal signaling and a novel pathway defined by the natural killer receptor KIR2DL4 (CD158d). Traffic 11: 1381-1390.
25. Kobayashi, T., M. C. Walsh, and Y. Choi. 2004. The role of TRAF6 in signal transduction and the immune response. Microbes Infect. 6: 1333-1338. (Pubitemid 39539732)
26. Chien, Y., C. Scuoppo, X. Wang, X. Fang, B. Balgley, J. E. Bolden, P. Premsrirut, W. Luo, A. Chicas, C. S. Lee, et al. 2011. Control of the senescence-associated secretory phenotype by NF-kB promotes senescence and enhances chemosensitivity. Genes Dev. 25: 2125-2136.
27. Rovillain, E., L. Mansfield, C. Caetano, M. Alvarez-Fernandez, O. L. Caballero, R. H. Medema, H. Hummerich, and P. S. Jat. 2011. Activation of nuclear factorkappa B signalling promotes cellular senescence. Oncogene 30: 2356-2366.
28. Rajagopalan, S., and E. O. Long. 2013. A positive role for senescence in reproduction? Aging (Albany, N.Y. Online) 5: 96-97.